Compare SECZ & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SECZ | CNMD |
|---|---|---|
| Founded | 2017 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 985.5M |
| IPO Year | 2026 | 1995 |
| Metric | SECZ | CNMD |
|---|---|---|
| Price | $13.95 | $45.83 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 7 |
| Target Price | $13.94 | ★ $45.50 |
| AVG Volume (30 Days) | ★ 3.6M | 261.1K |
| Earning Date | 11-20-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.22 |
| Revenue | N/A | ★ $1,374,724,000.00 |
| Revenue This Year | $16.24 | N/A |
| Revenue Next Year | $72.48 | $4.91 |
| P/E Ratio | ★ N/A | $38.59 |
| Revenue Growth | N/A | ★ 5.18 |
| 52 Week Low | $5.14 | $31.44 |
| 52 Week High | $17.00 | $53.66 |
| Indicator | SECZ | CNMD |
|---|---|---|
| Relative Strength Index (RSI) | 66.96 | 47.67 |
| Support Level | $5.86 | $44.39 |
| Resistance Level | N/A | $47.49 |
| Average True Range (ATR) | 1.42 | 1.31 |
| MACD | 0.39 | 0.02 |
| Stochastic Oscillator | 75.81 | 56.48 |
Securitize Holdings Inc provides a platform for tokenized real-world assets specializing in tokenizing real-world assets (RWAs) like funds, equities, and fixed income on blockchain networks. The company operates across two primary verticals: i) Tokenization: It consists of on-chain infrastructure and tokenization & distribution, ii) Asset Servicing: It covers post-issuance transfer agent and fund management services. The majority of the company's revenue is derived from the Tokenization vertical.
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.